Mixed Topics
Daily News Podcast
Antibody cleared amyloid plaques, slowed cognitive decline
And claims that cannabis relieves noncancer pain go up in smoke.
Daily News Podcast
Blood pressure meds cut cognitive impairment risk
And HIV infection may double patients’ stroke rate.
Conference Coverage
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
Clinicians are calling blood pressure drugs the first disease-modifying therapy for MCI.
Daily News Podcast
Is fish oil’s heart benefit a fish tale?
And how pregnancy and childbirth affect dementia risk.
Daily News Podcast
Is fibromyalgia one disorder – or two?
And breast cancer patients don’t get the financial counseling they want from their clinicians.
Daily News Podcast
Brain damage, slight benefit seen in epinephrine cardiac arrest
SGLT2 inhibitors, including dapagliflozin, appear to have a beneficial class effect.
Daily News Podcast
Bundle pay plan didn’t save money
Nearly 25% of presurgery patients in Michigan were already using opioids.
From the Journals
Epinephrine for cardiac arrest: Better survival, more brain damage
PARAMEDIC2 clears uncertainties in treating out-of-hospital cardiac arrest.
Daily News Podcast
Telemedicine payment expansion?
SGLT-2 inhibitor vs. DPP-4 inhibitor: SGLT-2 linked to lower mortality and lower cardiovascular risks.
Daily News Podcast
Managing HIV with diabetes
Intranasal naloxone is promising for hypoglycemia-associated autonomic failure.
Latest News
CREDENCE canagliflozin trial halted because of efficacy
Canagliflozin (Invokana) showed early renal benefits in CREDENCE.